These NSCLC phase 3 patients are less sick than those who were in the NSCLC phase 2 trial. These were part of the inclusion criteria for the phase 2 trial. “Eastern Cooperative Oncology Group (ECOG) Performance Status = 2.” These are the inclusion criteria for the phase 3 trial. “Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1” Here is the phase 2 clinical trials link: https://clinicaltrials.gov/ct2/show/NCT01138163?term=bavituximab&rank=8 Here is the phase 3 clinical trials link: https://clinicaltrials.gov/ct2/show/NCT01999673?term=bavituximab&rank=3 IMO sunstar